Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition
Scope of the Report
The report entitled “Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition”, provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.
The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.
Growth of the overall global TMVR market has also been forecasted for the years 2017-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Edward Lifesciences, Medtronic, and Abbott Laboratories are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Country Coverage
The US
Europe
Company Coverage
Edward Lifescience Incorporation
Abbott Laboratories
Medtronic
Executive Summary
The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time.
The causes of MR disease are congenital heart disorder, rheumatic fever, trauma, any other heart disease, radiation therapy, etc. The treatments available for MR disease are surgical repair, drug treatment and replacement. There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The DMR and FMR can further be subdivided into many types.
There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years.
Currently, the global TMVR market is in early stage, but is expected to increase at high growth rates during the forecasted period (2017-2022). The global TMVR market is supported by various growth drivers, such as aging population, high number of cases of congenital heart defects, rheumatic fever, low survival rate of surgical repair in FMR patients, etc. Yet, the market faces certain challenges, such as, complexity in design, success of repair surgery in DMR patients, high number of patients not referred for surgery, etc.
- 1. Executive Summary
- 2. Introduction
- 2.1 Heart Valves: An Overview
- 2.2 Mitral Regurgitation: An Overview
- 2.2.1 Transcatheter Mitral Valve Timeline
- Table 1: Transcatheter Mitral Valve Timeline
- 2.2.2 Types of MR
- Table 2: Types of Mitral Regurgitation
- Table 3: MR Surgery Class and Level
- 2.2.3 MR Clinical Guidelines
- Table 4: Transcatheter Mitral Valve Clinical Guidelines
- 2.3 Aortic Valve v/s Mitral Valve
- Table 5: Comparison of Aortic Valve and Mitral Valve
- 3. Market Sizing
- 3.1 Global Mitral Regurgitation Market: An Analysis
- 3.1.1 Global MR Market by Number of Patients
- Table 6: Global MR Market by Number of Patients; 2014-2016 (Million)
- Table 7: Global MR Market by Number of Patients; 2017-2022 (Million)
- 3.1.2 Global MR Market by Patient Severity
- Table 8: Global MR Market by Patient Severity and Eligibility for Treatment; 2014-2016
- Table 9: Global MR Market by Patient Severity and Eligibility for Treatment; 2017-2022
- 3.2 Global Degenerative Mitral Regurgitation Market: An Analysis
- 3.2.1 Global DMR Market by Number of Patients and Prevalence of TMVR
- Table 10: Global DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
- Table 11: Global DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
- 3.3 Global Functional Mitral Regurgitation Market: An Analysis
- 3.3.1 Global FMR Market by Number of Patients and Prevalence of TMVR
- Table 12: Global FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
- Table 13: Global FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
- 3.4 Global TMVR Market: An Analysis
- 3.4.1 Global TMVR Market by Value
- Table 14: Global TMVR Market by Value; 2014-2016 (US$ Million)
- Table 15: Global TMVR Market by Value; 2017-2022 (US$ Million)
- 3.4.2 Global TMVR Market by Volume
- Table 16: Global TMVR Market by Volume; 2014-2016 (Units)
- Table 17: Global TMVR Market by Volume; 2017-2022 (Units)
- 4. Regional Market Analysis
- 4.1 The US TMVR Market: An Analysis
- 4.1.1 The US MR Market by Number of Patients and Patient Severity
- Table 18: The US MR Market by Number of Patients; 2014-2022 (Million)
- Table 19: The US MR Market by Patient Severity; 2014-2022
- 4.1.2 The US DMR Market by Number of Patients and Prevalence of TMVR
- Table 20: The US DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
- Table 21: The US DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
- 4.1.3 The US FMR Market by Number of Patients and Prevalence of TMVR
- Table 22: The US FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
- Table 23: The US FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
- 4.1.4 The US TMVR Market by Value and Volume
- Table 24: The US TMVR Market by Value ; 2016-2022 (US$ Million
- Table 25: The US TMVR Market by Volume; 2016-2022 (Units)
- 4.2 Europe TMVR Market: An Analysis
- 4.2.1 Europe MR Market by Number of Patients and Patient Severity
- Table 26: Europe MR Market by Number of Patients; 2014-2022 (Million)
- Table 27: Europe MR Market by Patient Severity; 2014-2022 (Million)
- 4.2.2 Europe DMR Market by Number of Patients and Prevalence of TMVR
- Table 28: Europe DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 014-2022
- Table 29: Europe High Risk DMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
- 4.2.3 Europe FMR Market by Number of Patients and Prevalence of TMVR
- Table 30: Europe FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
- Table 31: Europe High Risk FMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
- 4.2.4 Europe TMVR Market by Value and Volume
- Table 32: Europe TMVR Market by Value; 2014-2022 (US$ Million)
- Table 33: Europe TMVR Market by Volume; 2014-2022 (Units)
- 5. Competitive Landscape
- 5.1 Global TMVR Market by Players
- Table 34: Companies in the Global TMVR Market
- Table 35: Global TMVR Market Players by Mitral Valve Repair Devices
- 5.2 Global TMVR Market by Key Players
- Table 36: Key Players in the Global TMVR Market: Overview
- 5.3 Comparison of Key Players in The Global TMVR Market by Design
- Table 37: Design Comparison of the Devices of Key Players in the Global TMVR Market
- 5.4 Global TMVR Market Players by Sales
- Table 38: Global TMVR Market by Top Four Players; 2016 (US$ Billion)
- 6. Company Profiling
- 6.1 Edward Lifecsiences Incorporation
- 6.1.1 Business Overview
- 6.1.2 Financial Overview
- Table 39: Edward Lifesciences Net sales; 2012-2016 (US$ Billion)
- Table 40: Edward Lifesciences Net sales by Segments; 2016 (Percentage, %)
- Table 41: Edward Lifesciences Net sales by Regions; 2016 (Percentage, %)
- 6.1.3 Business Strategy
- 6.2 Abbott Laboratories
- 6.2.1 Business Overview
- 6.2.2 Financial Overview
- Table 42: Abbott Laboratories Net Sales; 2012-2016 (US$ Billion)
- Table 43: Abbott Laboratories Net Sales by Segments; 2016 (Percentage, %)
- 6.2.3 Business Strategy
- 6.3 Medtronic
- 6.3.1 Business Overview
- 6.3.2 Financial Overview
- Table 44: Medtronic Net Sales; 2012-2016 (US$ Billion)
- Table 45: Medtronic Net Sales by Segments; 2016 (Percentage, %)
- Table 46: Medtronic Net Sales by Regions; 2016 (Percentage, %)
- 6.3.3 Business Strategy